Jonathan Pearce appointed as Chair of Cancer52

Cancer52 is delighted to announce that Jonathan Pearce, chief executive of the Lymphoma Association, has been appointed as Chair of Cancer52, succeeding interim Chair Clara Mackay.

Said Clara: "I’m delighted to be handing over this role to Jonathan at such an important point in Cancer52’s development. I am confident that Cancer52 will greatly benefit from Jonathan’s passion and experience - and that the voice of rare and less common cancers will be well represented where and when it matters."

Jonathan’s appointment takes effect from 21 April 2015.